CEO David Holmberg will continue as chief executive as well as board chairman, while Hanlon will also retain her current chief operating officer title, according to an announcement from Highmark.
Related Posts
DEA issues 4th extension of telehealth controlled substance flexibilities as debate enters 6th year
The fourth temporary extension continues the status quo of controlled substance prescribing via telehealth since 2020. It also puts into effect two other virtual prescribing […]
Tobacco Treatment As A Profit Center
The alignment of incentives is clear. Treatment of tobacco use improves patient health, lowers total medical expense, and, when done well, can generate positive financial […]
Ultrahuman and Click Therapeutics Launch World’s First Biomarker-Driven Migraine Tool
What You Should Know – Ultrahuman, the global leader in wearable health technology, has partnered with Click Therapeutics to develop the Migraine PowerPlug. This first-of-its-kind […]